<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Downs | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/nickelpig3/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/nickelpig3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Downs.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">7c05dbd2644bd5ef0e20fe104e387c27</guid>
				<title>Downs posted an update: Many systemic therapies for advanced hepatocellular [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36397/</link>
				<pubDate>Sun, 02 Feb 2025 10:05:34 -0800</pubDate>

									<content:encoded><![CDATA[<p>Many systemic therapies for advanced hepatocellular carcinoma (HCC) may cause hypothyroidism; however, in these patients, hypothyroidism prevalence before therapy and its prognostic impact remain unclear.</p>
<p> We previously established a prospective cohort of patients who received sorafenib as first-line therapy for advanced HCC. No patients&hellip;<span class="activity-read-more" id="activity-read-more-36397"><a href="http://www.nationalboardinstitute.com/activity/p/36397/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b1ad4b9b2cec488df3dc38c7d47052b8</guid>
				<title>Downs posted an update: These results suggest an earlier onset of structural [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34619/</link>
				<pubDate>Fri, 31 Jan 2025 10:11:45 -0800</pubDate>

									<content:encoded><![CDATA[<p>These results suggest an earlier onset of structural luteolysis in pigs caused by MXC actions in neonates. Since negative correlation analysis showed the potential interactions of miRNAs with specific messenger RNAs, we propose that these miRNAs are potential mediators of the long-term MXC effect on the CL function in pigs.This panel was designed&hellip;<span class="activity-read-more" id="activity-read-more-34619"><a href="http://www.nationalboardinstitute.com/activity/p/34619/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1bb9d2da007880d6603b92a79f2f7425</guid>
				<title>Downs posted an update: This case report highlights the importance of early [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33615/</link>
				<pubDate>Thu, 30 Jan 2025 09:57:02 -0800</pubDate>

									<content:encoded><![CDATA[<p>This case report highlights the importance of early proactive and collaborative multidisciplinary approach, maintaining normal temperature and electrolytes with a heightened vigilance for muscle-related perioperative complications.</p>
<p> Somatic variant callers are used to find mutations in sequencing data from cancer samples. They are very&hellip;<span class="activity-read-more" id="activity-read-more-33615"><a href="http://www.nationalboardinstitute.com/activity/p/33615/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c6d3ed04cb573a8290f7622f2d1c3e64</guid>
				<title>Downs posted an update: 345). When compared to the one-implant configuration, adding [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/26776/</link>
				<pubDate>Tue, 28 Jan 2025 08:26:52 -0800</pubDate>

									<content:encoded><![CDATA[<p>345). When compared to the one-implant configuration, adding a second implant further statistically decreased VD (- 10% ± 7%, p = 0.046) and AD (- 19% ± 15, p = 0.046). Adding a third implant did not lead to additional stabilization for VD nor AD (p &gt; 0.5).</p>
<p> Compared to the non-instrumented initial state, the two-implant configuration&hellip;<span class="activity-read-more" id="activity-read-more-26776"><a href="http://www.nationalboardinstitute.com/activity/p/26776/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0fb7f861201ce8c88d1e3ce78b872286</guid>
				<title>Downs became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/26688/</link>
				<pubDate>Tue, 28 Jan 2025 08:20:02 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>